(Q36675877)

15 August 2017

1 reference

title

Diabetic neuropathy differs in type 1 and type 2 diabetes (English)

1 reference

15 August 2017

0 references

1 reference

1 reference

Anders A F Sima

1

1 reference

15 August 2017

Hideki Kamiya

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Annals of the New York Academy of Sciences

15 August 2017

published in

1 reference

15 August 2017

volume

1084

1 reference

15 August 2017

page(s)

235-249

1 reference

New insights into the metabolic and molecular basis for diabetic neuropathy

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Diabetic neuropathy: pathogenetic background, current and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Reversible nervous abnormalities in juvenile diabetics with recently diagnosed diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Molecular basis for the insulinomimetic effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Neuropathic pain and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Neurobiology of neuropathic pain: mode of action of anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Neurons undergo apoptosis in animal and cell culture models of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.004

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1372.004

1 reference

15 August 2017

1 reference